Sign inJoin waitlistJoin the waitlist

Back to University of California (San Diego) Medical Center Urology

Aditya Bagrodia

Urology Residency · University of California (San Diego) Medical Center

Credentials: · · · ·

History

Urology
University of California (San Diego) Medical Center
2025–Present
Univ of Tennessee Coll of Med
2005–2009

Research

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets
European Urology · 2017 · 299 citations
Single-incision, umbilical laparoscopic versus conventional laparoscopic nephrectomy: a comparison of perioperative outcomes and short-term measures of convalescence
European Urology · 2009 · 276 citations
Laboratory and clinical development of single keyhole umbilical nephrectomy
Urology · 2007 · 243 citations

Vitaly Margulis
88 papers
Yair Lotan
74 papers
Solomon Woldu
66 papers · 23 as a fellow
Nirmish Singla
46 papers · 36 as a resident
AS
Arthur Sagalowsky
34 papers
Payal Kapur
33 papers
Rana McKay
32 papers · 19 as a resident
Brent Rose
25 papers · 17 as a resident
Jay Raman
25 papers · 14 as a fellow
LK
Laura-Maria Krabbe
24 papers · 11 as a resident
Jeffrey Cadeddu
23 papers
Kshitij Pandit
23 papers · 15 as a resident

Clinical trials

Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Prostate Cancer
Principal investigator · Not yet recruiting · Phase 2
Aditya Bagrodia
2026–2030
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2035
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2021–2027
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2018–2031